This training introduces the principles of clinical endpoints, surrogates, and biomarkers, exploring how they relate to therapeutic indications and labeling. It covers patient-reported outcomes and their role in regulatory submissions, alongside global and African initiatives promoting concurrent review and collaboration in regulatory decision-making.